Aeterna Zentaris
AEZS
#10305
Rank
NZ$30.36 M
Marketcap
NZ$9.92
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): NZ-$3.38

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is NZ-$3.55. In 2022 the company made an earnings per share (EPS) of NZ-$8.12 a decrease over its 2021 EPS that were of NZ-$3.16.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)NZ-$3.38
2022NZ-$8.12157.14%
2021NZ-$3.16-41.48%
2020NZ-$5.39-64.46%
2019NZ-$15.17-240%
2018NZ$10.84-122.32%
2017NZ-$48.55-53.53%
2016NZ-$104.48-86.71%
2015NZ-$786.41-35.21%
2014NZ-$1,214-216.67%
2013NZ$1,040-123.3%
2012NZ-$4,465-40.8%
2011NZ-$7,543-6.45%
2010NZ-$8,064-27.91%
2009NZ-$11,185-61.61%
2008NZ-$29,13383.61%
2007NZ-$15,867-195.31%
2006NZ$16,647178.26%
2005NZ$5,983-330%
2004NZ-$2,601-80.05%
2003NZ-$13,03817.78%
2002NZ-$11,070515.93%
2001NZ-$1,797-68.6%
2000NZ-$5,724119.62%
1999NZ-$2,606-3.63%
1998NZ-$2,705

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.49-451.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$3.58-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$6.00-268.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.62-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
NZ$4.53-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA